A Comparative Study Between Laser and Manual Removal of Corneal Epithelium for Photorefractive Keratectomy
1 other identifier
observational
64
0 countries
N/A
Brief Summary
Photorefractive keratectomy (PRK) is a laser eye surgery used to ablate the corneal stroma to correct visual refractive errors . PRK was developed in 1983 by Dr. Steven Trokel and colleagues and first performed in 1987 by Dr. Theo Seiler in Berlin. After receiving approval by the US Food and Drug Administration (FDA) in 1996, PRK was briefly the preferred surgical treatment of ametropia as it provided more predictable and stable results than incisional keratotomy. However, the number of PRK procedures fell in the late 1990s with the growing popularity of laser in situ keratomileusis (LASIK). The study aims to compare the visual and refractive outcomes along with the pain score and patient satisfaction after photorefractive keratectomy in patients who underwent transepithelial or mechanical removal technique
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 27, 2024
December 1, 2024
1 year
December 19, 2024
December 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual acuity
best corrected visual acuity (BCVA) will be observed for at least 6 months postoperatively.
6 month
Study Arms (2)
group A
patients who are assigned for transepithelial PRK
group B
patients who are mechanical PRK using a spatula
Eligibility Criteria
Patients in the age group between 18 and 45 years will be included in this study. Subjects selected, which will consist of patients with myopia ( less than - 6 D ) will be divided into 2 groups.
You may qualify if:
- Age : older than 18 years old .
- Gender: Include both males and females.
- Stable refraction for at least 12 months .
- Intraocular pressure less than 21mmHg.
- A period without wearing contact lenses (more than 4 days for soft , more than 2 weeks for rigid contact lenses )
- No history of any Autoimmune disease .
- The refractive error must be one that can be treated by PRK
You may not qualify if:
- \_ patients with any eye disease (significant cataract or unstable glaucoma )
- uncontrolled external disease such as blepharitis, dry eye syndrome, and atopy/allergy.
- patients with Keratoconus and other abnormalities of the cornea such as corneal ectasias , thinning , edema , interstitial or neurotrophic keratitis and extensive vascularisation .
- Patients with active systemic connective tissue disease such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)
- Ineligibility for Surgery: Exclude patients who are not suitable candidates for surgery .
- Consider excluding pregnant or lactating women .
- Patients unwilling to participate in the study .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Edwards JD, Bower KS, Sediq DA, Burka JM, Stutzman RD, Vanroekel CR, Kuzmowych CP, Eaddy JB. Effects of lotrafilcon A and omafilcon A bandage contact lenses on visual outcomes after photorefractive keratectomy. J Cataract Refract Surg. 2008 Aug;34(8):1288-94. doi: 10.1016/j.jcrs.2008.04.024.
PMID: 18655978BACKGROUNDGamaly TO, El Danasoury A, El Maghraby A. A prospective, randomized, contralateral eye comparison of epithelial laser in situ keratomileusis and photorefractive keratectomy in eyes prone to haze. J Refract Surg. 2007 Nov;23(9 Suppl):S1015-20. doi: 10.3928/1081-597X-20071102-07.
PMID: 18047000BACKGROUNDDiakonis VF, Pallikaris A, Kymionis GD, Markomanolakis MM. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol. 2007 Jul;144(1):99-103. doi: 10.1016/j.ajo.2007.03.039. Epub 2007 May 23.
PMID: 17509511BACKGROUNDBarreto J Jr, Netto MV, Reis A, Nakano M, Alves MR, Bechara SJ. Topography-guided (NIDEK customized aspheric treatment zone) photorefractive keratectomy with mitomycin C after penetrating keratoplasty for keratoconus: case report. J Refract Surg. 2009 Jan;25(1 Suppl):S131-5. doi: 10.3928/1081597X-20090115-10.
PMID: 19248542BACKGROUNDAlio JL, Soria FA, Abbouda A, Pena-Garcia P. Fifteen years follow-up of photorefractive keratectomy up to 10 D of myopia: outcomes and analysis of the refractive regression. Br J Ophthalmol. 2016 May;100(5):626-32. doi: 10.1136/bjophthalmol-2014-306459. Epub 2015 Sep 10.
PMID: 26359339BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor at Assiut University hospital
Study Record Dates
First Submitted
December 19, 2024
First Posted
December 27, 2024
Study Start
January 1, 2025
Primary Completion
January 1, 2026
Study Completion
March 1, 2026
Last Updated
December 27, 2024
Record last verified: 2024-12